A Multicenter, Open-Label, Interventional Study to Evaluate Subject Satisfaction of AbobutulinumtoxinA Treatments in Moderate to Severe Glabellar Lines
Active, no longer recruiting
Phase of Trial: Phase IV
Latest Information Update: 20 Dec 2018
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Glabellar lines
- Focus Therapeutic Use
- Acronyms DREAM
- Sponsors Q-Med
- 11 Dec 2018 Status changed from recruiting to active, no longer recruiting.
- 05 Oct 2018 New trial record
- 02 Oct 2018 Status changed from not yet recruiting to recruiting.